Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites
- PMID: 1277214
Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites
Abstract
Recent evidence has implicated phosphoramide mustard as a highly active metabolite of cyclophosphamide (CP). This compound has been shown to be produced from CP both in vitro and in vivo. To further study the role of this active metabolite we have devised methods to quantitate the compound in human serum and urine using gas chromatography-chemical ionization mass spectrometry. Tetradeuterated phosphoramide mustard has been synthesized and is used as an internal standard. CP and nor-nitrogen mustard have also been quantitated in human samples using analogous tetradeuterated internal standards.
Similar articles
-
Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.Cancer Res. 1978 Feb;38(2):408-15. Cancer Res. 1978. PMID: 620410
-
Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.Cancer Treat Rep. 1976 Apr;60(4):415-22. Cancer Treat Rep. 1976. PMID: 1277216
-
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.Biol Mass Spectrom. 1994 Mar;23(3):149-58. doi: 10.1002/bms.1200230306. Biol Mass Spectrom. 1994. PMID: 8148406
-
Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.Arzneimittelforschung. 1982;32(9):995-1012. Arzneimittelforschung. 1982. PMID: 6756419 Review.
-
The analysis of cyclophosphamide and its metabolites.Curr Pharm Des. 1999 Aug;5(8):561-86. Curr Pharm Des. 1999. PMID: 10469892 Review.
Cited by
-
A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.Br J Clin Pharmacol. 1978 Oct;6(4):373-6. doi: 10.1111/j.1365-2125.1978.tb00869.x. Br J Clin Pharmacol. 1978. PMID: 698034 Free PMC article. No abstract available.
-
Preclinical pharmacokinetics and stability of isophosphoramide mustard.Cancer Chemother Pharmacol. 1994;33(5):391-8. doi: 10.1007/BF00686268. Cancer Chemother Pharmacol. 1994. PMID: 8306413
-
The disposition of cyclophosphamide in a group of myeloma patients.Cancer Chemother Pharmacol. 1979;3(4):253-9. doi: 10.1007/BF00254741. Cancer Chemother Pharmacol. 1979. PMID: 535136
-
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.Cancer Chemother Pharmacol. 1978;1(4):229-31. doi: 10.1007/BF00257155. Cancer Chemother Pharmacol. 1978. PMID: 750109
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous